Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

"We show that if you can see where a virus is evolving ahead of time, you can begin to make future-proof vaccines," said first author Noor Youssef, a scientific lead for the Predictive Modeling for ...

Robert F. Kennedy Jr. secures a prominent health role, pledging reform in vaccine approval. The FDA plans significant changes ...

A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...

Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond infectious diseases.

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

A similar paradigm has unfolded for Covid-19 vaccines since they were first authorized in the height of the pandemic at the end of 2020. HHS’s new initiative also aims to develop universal ...